期刊
DERMATOLOGIC CLINICS
卷 29, 期 4, 页码 613-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.det.2011.06.003
关键词
Bullous pemhigoid; Autoimmune bullous disease; Topical corticosteroids; Systemic corticosteroids
类别
资金
- Swiss National Foundation for Scientific Research [31003A-121966, 31003A-09811]
- European Community [1-HEALTH-F2-2008-200515]
- Swiss National Science Foundation (SNF) [31003A_121966] Funding Source: Swiss National Science Foundation (SNF)
Bullous pemphigoid (BP) is the most common autoimmune subepidermal bullous disease typically affecting the elderly. Although different therapeutic regimens have been proposed, a review of the evidence is needed to aid clinicians in their decision making and management. Systemic therapies such as corticosteroids and adjuvants are effective in BP but are plagued with adverse effects, and potent topical steroids are an alternative treatment. This article reviews the evidence supporting different therapeutic options in the management of BP.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据